Studies related to Cognitive Decline and Piracetam

[On The Dose-effect Relationship In The Therapy With Piracetam (author's Transl)]

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 78
Sex n/a
Notes for this study:
When comparing 800mg thrice a day (2400mg) against 1600mg thrice aday (4800mg) in persons with organic cognitive decline aged 73.2 years, benefit was only seen with the higher dose over a period of 6 weeks.

Full details on all 6 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.